Skip to main content
SpringerLink
Log in

5-Hydroxytryptamine (5-HT) contracts the guinea-pig isolated iliac artery via 5-HT1-like and 5-HT2 receptors

  • Original Articles
  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Summary

The characterization of 5-hydroxytryptamine (5-HT) receptors mediating contractions of the guinea-pig isolated iliac artery was studied when the basal tone was slightly increased by prostaglandin F2α (PGF2α).

In the presence of ketanserin (1 μmol/l), 5-HT and several 5-HT receptor agonists induced contractile responses with the rank order of agonist potency: 5-HT = 5-carboxamidotryptamine (5-CT) = lysergol > ergometrine = methylergometrine > RU 24969 ≈ 5-methoxytryptamine (5-MeOT) > methysergide > sumatriptan > tryptamine. Concentration-effect curves to the ergot alkaloids, lysergol, ergometrine, methylergometrine and methysergide, were biphasic.

In the presence of ketanserin (1 μmol/l), contractile responses to 5-HT, 5-CT, RU 24969, 5-MeOT, sumatriptan and tryptamine were antagonized by methiothepin (30 nmol/l) and flesinoxan (3 μmol/l) with approximate pKB values of 8.5–9.0 and 6.0–6.3, respectively. The first phase of contraction produced by the ergot alkaloids, lysergol, ergometrine, methylergometrine and methysergide, were blocked by methiothepin (30 nmol/l) and flesinoxan (3 μmol/l), respectively, with approximate pKB values about 8.4–8.7 and 6.2–6.4, respectively. The mechanism underlying the second phase of contraction remains to be established.

Maximum responses of the concentration-effect curves to 5-HT (1 nmol/l-1 μmol/l) were concentration-dependently depressed by ketanserin (1 nmol/l-1 μmol) and spiperone (30 nmol/l-0.3 μmol/l) and reached approximately 60% of the 5-HT maximum response in the presence of ketanserin (1 μmol/l) and spiperone (0.1 μmol/l), respectively. Agonist potency of 5-HT was not affected by the antagonists. 5-HT (1 nmol/l-1 mmol) produced biphasic concentration-effect curves (first phase: 1 nmol/l-1 gmol/l; second phase: 1 μmol/l-1 mmol/l) in the presence of ketanserin (100 and 300 nmol/l), spiperone (100 and 300 nmol/l), (R)-α-methylketanserin (3 μmol/l) and (S)-α-methylketanserin (10 nmol/l). Contractions mediating the first phase of the effects of 5-HT accounted for approximately 60% of the 5-HT maximum response and were resistant to blockade by the antagonists. pKB values at the receptor mediating the second phase of the effects of 5-HT were 9.2–9.3 for ketanserin, 9.2–9.6 for spiperone, 10.5 for (S)-α-methylketanserin and 7.2 for (R)-α-methylketanserin.

It is concluded that 5-HT contracts the guinea-pig isolated iliac artery via a mixture of 5-HT1-like receptors and 5-HT2 receptors. At low concentrations contractions are mediated via 5-HT1-like receptors which accounted for approximately 60% of the 5-HT maximum response. At higher concentrations 5-HT-induced contractions are mediated via 5-HT2 receptors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Bax WA, Van Heuven-Nolsen D, Bos E, Simoons ML, Saxena PR (1992) 5-Hydroxytryptamine-induced contractions of the human isolated saphenous vein: involvement of 5-HT2 and 5-HT1D-like receptors, and a comparison with grafted veins. Naunyn-Schmiedeberg's Arch Pharmacol 345:500–508

    Google Scholar 

  • Clancy BM, Maayani S (1985) 5-Hydroxytryptamine receptor in isolated rabbit aorta: characterization with tryptamine analogs. J Pharmacol Exp Ther 233:761–769

    Google Scholar 

  • Connor HE, Feniuk W, Humphrey PPA (1989a) 5-Hydroxytryptamine contracts human coronary arteries predominantly via 5-HT2 receptor activation. Eur J Pharmacol 161:91–94

    Google Scholar 

  • Connor HE, Feniuk W, Humphrey PPA (1989b) Characterization of 5-HT receptors mediating contraction of canine and primate basilar artery by use of GR43175, a selective 5-HT1-like receptor agonist. Br J Pharmacol 96:379–387

    Google Scholar 

  • Den Boer MO, Heiligers JPC, Saxena PR (1991) Carotid vascular effects of ergotamine and dihydroergotamine in the pig: no exclusive mediation via 5-HT1-like receptors. Br J Pharmacol 104:183–189

    Google Scholar 

  • Docherty JR, Hyland L (1986) An examination of 5-hydroxytryptamine receptors in human saphenous vein. Br J Pharmacol 89:77–81

    Google Scholar 

  • Dreteler GH, Wouters W, Saxena PR (1990) Comparison of the cardiovascular effects of the 5-HT1A receptor agonist flesinoxan with that of 8-OH-DPAT in the rat. Eur J Pharmacol 180:339–349

    Google Scholar 

  • Edvinsson L, Nielsen KC, Owman Ch (1974) Influence of initial tension and changes in sensitivity during amine-induced contractions of pial arteries in vitro. Arch Int Pharmacodyn 208:235–242

    Google Scholar 

  • Elz S (1991) Chiral 5-HT2 receptor ligands: stereoselectivity of optically active analogues of ketanserin. Naunyn-Schmiedeberg's Arch Pharmacol 343:R100

    Google Scholar 

  • Feniuk W, Humphrey PPA, Perren MJ, Watts AD (1985) A comparison of 5-hydroxytryptamine receptors mediating contraction in rabbit aorta and dog saphenous vein: evidence for different receptor types obtained by use of selective agonists and antagonists. Br J Pharmacol 86:697–704

    Google Scholar 

  • Frenken M, Kaumann AJ (1988) Effects of tryptamine mediated through 2 states of the 5-HT2 receptor in calf coronary artery. Naunyn-Schmiedeberg's Arch Pharmacol 337:484–492

    Google Scholar 

  • Furchgott RF (1972) The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory. In: Blaschko H, Muscholl E (eds) Catecholamines, Handbook of experimental pharmacologicy, vol 33. Springer, Berlin Heidelberg New York, pp 283–335

    Google Scholar 

  • Glusa E, Müller-Schweinitzer E (1993) Heterogeneity of 5-HT receptor subtypes in isolated human femoral and saphenous veins. Naunyn-Schmiedeberg's Arch Pharmacol 347–133–136

    Google Scholar 

  • Hamel E, Robert JP, Young AR, MacKenzie ET (1989) Pharmacological properties of the receptor(s) involved in the 5-hydroxytryptamine-induced contraction of the feline middle cerebral artery. J Pharmacol Exp Ther 249:879–889

    Google Scholar 

  • Hamel E, Bouchard D (1991) Contractile 5-HT1 receptors in human isolated pial arterioles: correlation with 5-HT1D binding sites. Br J Pharmacol 102:227–233

    Google Scholar 

  • Hartig PR, Branchek TA, Weinshank RL (1992) A subfamily of 5-HT1D receptor genes. Trends Pharmacol Sci 13:152–159

    Google Scholar 

  • Humphrey PPA, Feniuk W, Perren MJ, Connor HE, Oxford AW, Coates IH, Butina D (1988) GR43175, a selective agonist for the 5-HT1-like receptor in dog isolated saphenous vein. Br J Pharmacol 94:1123–1132

    Google Scholar 

  • Kaumann AJ, Brown AM (1990a) Human coronary artery spasm induced by 5-hydroxytryptamine: role of receptor subtypes, plaque and stenosis. Naunyn-Schmiedeberg's Arch Pharmacol 341:R90

    Google Scholar 

  • Kaumann AJ, Brown AM (1990b) Allosteric modulation of arterial 5-HT2 receptors. In: Saxena PR, Wallis DI, Wouters W, Bevan P (eds) Cardiovascular pharmacology of 5-hydroxytryptamine. Prospective therapeutic applications. Kluwer, Dordrecht Boston London, pp 127–142

    Google Scholar 

  • Kaumann AJ, Parsons AA, Brown AM (1993) Human artery contractile 5-HT1-like receptors resemble more 5-HT1Dβ than 5-HT1Dα receptors. Naunyn-Schmiedeberg's Arch Pharmacol 347:R125

    Google Scholar 

  • MacLennan SJ, Martin GR (1990) Actions of non-peptide ergot alkaloids at 5-HT1-like and 5-HT2 receptors mediating vascular smooth muscle contraction. Naunyn-Schmiedeberg's Arch Pharmacol 342:120–129

    Google Scholar 

  • MacLennan SJ, Martin GR (1992) Effect of thromboxane A2-mimetic U46619 on 5-HT1-like and 5-HT2 receptor-mediated contraction of the rabbit isolated femoral artery. Br J Pharmacol 107:418–421

    Google Scholar 

  • Martin GR, MacLennan SJ (1990) Analysis of the 5-HT receptor in rabbit saphenous vein exemplifies the problems of using exclusion criteria for receptor classification. Naunyn-Schmiedeberg's Arch Pharmacol 342:111–119

    Google Scholar 

  • Mylecharane EJ (1990) Agonists and antagonists of 5-HT2 receptors. In: Saxena PR, Wallis DI, Wouters W, Bevan P (eds) Cardiovascular pharmacology of 5-hydroxytryptamine. Prospective therapeutic applications. Kluwer, Dordrecht Boston London, pp 81–100

    Google Scholar 

  • Parsons AA (1991) 5-HT receptors in human and animal cerebrovasculature. Trends Pharmacol Sci 12:310–314

    Google Scholar 

  • Perren MJ, Feniuk W, Humphrey PPA (1991) Vascular 5-HT1-like receptors that mediate contraction of the dog isolated saphenous vein and carotid arterial vasoconstriction in anaesthetized dogs are not of the 5-HT1A or 5-HT1D subtype. Br J Pharmacol 102:191–197

    Google Scholar 

  • Sahin-Erdemli I, Hoyer D, Stoll A, Seiler MP, Schoeffter P (1991) 5-HT1-like receptors mediate 5-hydroxytryptamine-induced contraction of guinea-pig isolated iliac artery. Br J Pharmacol 102: 386–390

    Google Scholar 

  • Saxena PR, Villalon CM (1990) Cardiovascular effects of serotonin agonists and antagonists. J Cardiovasc Pharmacol 15 [Suppl 7]: S17-S34

    Google Scholar 

  • Schoeffter P, Sahin-Erdemli I (1992) Further characterization of the 5-hydroxytryptamine 5-HT1-like receptor mediating contraction of guinea-pig iliac artery. Eur J Pharmacol 219:295–301

    Google Scholar 

  • Tadipatri S, Feniuk W, Saxena PR (1992) Rabbit isolated renal artery contractions by some tryptamine derivatives, including 2-methyl-5-HT, are mediated by a 5-HT1-like receptor. Br J Pharmacol 107:322–328

    Google Scholar 

  • Templeton AGB, McGrath JC, Whittle MJ (1991) The role of endogenous thromboxane in contractions to U46619, oxygen, 5-HT and 5-CT in the human isolated umbilical artery. Br J Pharmacol 103:1079–1084

    Google Scholar 

  • Toda N, Okamura T (1990) Comparison of the response to 5-carboxamidotryptamine and serotonin in isolated human, monkey and dog coronary arteries. J Pharmacol Exp Ther 253:676–682

    Google Scholar 

  • Van Heuven-Nolsen D, Tysse Klasen THM, Luo Q, Saxena PR (1990) 5-HT1-like receptors mediate contractions of the rabbit saphenous vein. Eur J Pharmacol 191:375–382

    Google Scholar 

  • Victorzon M, Tapparelli C, Müller-Schweinitzer E (1986) Comparison of the actions of serotoninergic agents on human saphenous veins and platelets. Eur J Pharmacol 124:107–111

    Google Scholar 

  • Weinshank RL, Zgombick JM, Macchi MJ, Branchek TA, Hartig PR (1992) Human serotonin 1 receptor is encoded by a subfamily of two distinct genes: 5-HT1Dα and 5-HT1Dβ. Proc Natl Acad Sci USA 89:3630–3634

    Google Scholar 

  • Wouters W, Tulp MTM, Bevan P (1988) Flesinoxan lowers blood pressure and heart rate in cats via 5-HT1A receptors. Eur J Pharmacol 149:213–223

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Fachbereich Pharmazie, Freie Universität Berlin, Königin-Luise-Straße 2+4, D-14195, Berlin, Germany

    H. Pertz

Authors
  1. H. Pertz
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pertz, H. 5-Hydroxytryptamine (5-HT) contracts the guinea-pig isolated iliac artery via 5-HT1-like and 5-HT2 receptors. Naunyn-Schmiedeberg's Arch Pharmacol 348, 558–565 (1993). https://doi.org/10.1007/BF00167230

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00167230

Key words

Search

Navigation